+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sunitinib"

Sunitinib Generics Market - Global Forecast 2025-2030 - Product Thumbnail Image

Sunitinib Generics Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
From
From
Sunitinib Malate Market - Global Forecast 2025-2032 - Product Thumbnail Image

Sunitinib Malate Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 191 Pages
  • Global
From
VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Anti-VEGF Therapy for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

Anti-VEGF Therapy for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
From
Sunitinib Malate - Global Strategic Business Report - Product Thumbnail Image

Sunitinib Malate - Global Strategic Business Report

  • Report
  • October 2025
  • 193 Pages
  • Global
From
Kidney Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Kidney Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 148 Pages
  • Global
From
From
Kidney Cancer Drugs Market Report 2025 - Product Thumbnail Image

Kidney Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Gastric Cancer Drugs Market Report 2025 - Product Thumbnail Image

Gastric Cancer Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Renal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 180 Pages
  • Global
From
RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

RET (Ret Proto-Oncogene) Protein Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
Loading Indicator

Sunitinib is an oncology drug used to treat a variety of cancers, including gastrointestinal stromal tumors, renal cell carcinoma, and pancreatic neuroendocrine tumors. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain proteins that can cause cancer cells to grow and divide. Sunitinib is typically administered orally, and is available in both capsule and tablet form. Sunitinib is a relatively new drug, having been approved by the US Food and Drug Administration in 2006. It has since become a popular treatment option for many types of cancer, due to its effectiveness and relatively low side effects. Sunitinib is also used in combination with other drugs to treat certain types of cancer, such as advanced renal cell carcinoma. Some of the companies in the Sunitinib market include Pfizer, Novartis, and AstraZeneca. These companies manufacture and distribute the drug, as well as provide support and resources for patients and healthcare professionals. Show Less Read more